KLRK1 and neoplasm: This molecule comprises a MICA extracellular domain (MICA-ECD) for NKG2D binding, an anti-CD20 single-chain variable fragment (ScFv) for CD20 recognition on tumor cells, and a human IgG Fc fragment.